Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for treating spinal atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
REGISTERED
on 24 Nov 2020
ONREPLA
NOVARTIS AG
1897224 · 03 May 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for treating spinal atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
Pharmaceutical preparations and gene therapy products in the nature of...
